CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancers

High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer

Engineered prime editors with PAM flexibility.

Discovery of acquired molecular signature on immune checkpoint inhibitors in paired tumor tissues.

Intensity of metastasis screening and survival outcomes in patients with breast cancer.